Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 71NIH 4NETWORK 4INDUSTRY 3UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Esophageal Neoplasms 3Breast Neoplasms 3Lung Neoplasms 2Carcinoma, Hepatocellular 2To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Ototoxicity 1Neoplasms 1MSS Metastatic Colorectal Cancer 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Ketosis 1Insulin Resistance 1Hearing Loss 1Glioma 1Germinoma 1Esophageal Squamous Cell Carcinoma 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 3sintilimab 2toripalimab 1camrelizumab 1anlotinib 1TP protocol 1Radiotherapy 1Radiation 1Paclitaxel 1Nivolumab 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Fluorouracil 1Docetaxel 1Chemoradiotherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Esophageal Squamous Cell Carcinoma × Radiotherapy × Clear all
NCT06354530 2024-04-09

A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Army Medical Center of PLA

Phase 2/3 Recruiting
266 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡